Skye Bioscience, Inc. (SKYE)
NASDAQ·Healthcare·Biotechnology
$0.96
-3.06%
Mkt Cap $8.85M
Analyst Ratings
No recent rating data.
Price Target (8 analysts)
$12.00
Range $2.00 – $21.00
Implied Upside
+1150.0%
Consensus $12.00 vs current $0.96
NASDAQ·Healthcare·Biotechnology
$0.96
-3.06%
Mkt Cap $8.85M
No recent rating data.
Price Target (8 analysts)
$12.00
Range $2.00 – $21.00
+1150.0%
Consensus $12.00 vs current $0.96